Literature DB >> 10873611

Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines.

G McEachern1, S Kassovska-Bratinova, S Raha, M A Tarnopolsky, J Turnbull, J Bourgeois, B Robinson.   

Abstract

The most frequent genetic causes of amyotrophic lateral sclerosis (ALS) determined so far are mutations occurring in the gene for copper/zinc superoxide dismutase (CuZnSOD). The mechanism may involve inappropriate formation of hyroxyl radicals, peroxynitrite or malfunctioning of the SOD protein. We hypothesized that undiscovered genetic causes of sporadically occurring amyotrophic lateral sclerosis might be found in the mechanisms that create and destroy oxygen free radicals within the cell. After determining that there were no CuZnSOD mutations present, we measured superoxide production from mitochondria and manganese superoxide dismutase (MnSOD), glutathione peroxidase, NFkappaB, Bcl-2 and Bax by immunoblot. Of the ten sporadic patients we tested we found three patients with significantly increased concentrations of MnSOD. These patients also had lower levels of superoxide production from mitochondria and decreased expression of Bcl-2. No mutations were found in the cDNA sequence of either MnSOD in any of the sporadic patients. A patient with a CuZnSOD mutation (G82R) used as a positive control showed none of these abnormalities. The patients displaying the MnSOD aberrations showed no specific distinguishing features. This result suggests that the cause of ALS in a subgroup of ALS patients (30%) is genetic in origin and can be identified by these markers. The alteration in MnSOD and Bcl-2 are likely epiphenomena resulting from the primary genetic defect. It suggests also that the oxygen free radicals are part of the cause in this subgroup and that dysregulation of MnSOD or increased endogenous superoxide production might be responsible. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873611     DOI: 10.1006/bbrc.2000.2933

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA.

Authors:  Fenghao Xu; Charles Morin; Grant Mitchell; Cameron Ackerley; Brian H Robinson
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 2.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

Review 3.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

4.  Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.

Authors:  Raquel Manzano; Janne M Toivonen; Ana Cristina Calvo; Sara Oliván; Pilar Zaragoza; Maria Jesús Muñoz; Didier Montarras; Rosario Osta
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

5.  A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16.

Authors:  N Lee; M J Daly; T Delmonte; E S Lander; F Xu; T J Hudson; G A Mitchell; C C Morin; B H Robinson; J D Rioux
Journal:  Am J Hum Genet       Date:  2001-01-10       Impact factor: 11.025

6.  Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.

Authors:  Christian Lunetta; Andrea Lizio; Valeria A Sansone; Nadia Maria Cellotto; Eleonora Maestri; Massimo Bettinelli; Valentina Gatti; Mario Giovanni Melazzini; Giovanni Meola; Massimo Corbo
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

7.  FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription.

Authors:  Sanjit Kumar Dhar; Jiayu Zhang; Jozsef Gal; Yong Xu; Lu Miao; Bert C Lynn; Haining Zhu; Edward J Kasarskis; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2013-09-20       Impact factor: 8.401

8.  Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

Authors:  Margaret Wong; Lee J Martin
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

Review 9.  Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Authors:  Sandra R Bacman; Walter G Bradley; Carlos T Moraes
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 10.  More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases.

Authors:  Justin G Boyer; Andrew Ferrier; Rashmi Kothary
Journal:  Front Physiol       Date:  2013-12-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.